Central South University (CSU), founded in 2000 and located in Changsha, China, is a prestigious institution known for its beautiful campuses and comprehensive academic offerings. As one of the first universities included in China's "Project 211" and "Project 985," CSU has established itself as a leader in research and innovation, particularly in fields such as Non-ferrous Metals, Medicine, and Engineering.

The PhD in Pathology and Pathophysiology (Pathogenesis of Malignant Tumor) program at CSU provides students with an in-depth understanding of the mechanisms behind tumor development and progression. Students will engage in advanced research, exploring key topics in cancer pathology and pathophysiology, which will prepare them for careers in academia, research institutions, or the healthcare industry. This program is distinguished by its emphasis on innovative research capabilities and access to cutting-edge facilities, enabling graduates to contribute significantly to advancements in cancer treatment and prevention.